[REGN] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 4.07%
YoY- -23.40%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 3,362,700 2,936,200 3,452,800 2,294,000 2,048,400 1,663,496 1,500,673 14.38%
PBT 1,110,800 1,509,800 1,816,600 998,300 768,500 635,861 565,605 11.90%
Tax 103,000 194,100 184,400 156,200 98,900 41,206 177,288 -8.64%
NP 1,007,800 1,315,700 1,632,200 842,100 669,600 594,655 388,317 17.21%
Tax Rate -9.27% -12.86% -10.15% -15.65% -12.87% -6.48% -31.34% -
Total Cost 2,354,900 1,620,500 1,820,600 1,451,900 1,378,800 1,068,841 1,112,356 13.30%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 29.97 44.81 47.27 36.71 32.69 35.75 25.88 2.47%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS 9.48 11.66 15.37 7.98 6.12 5.51 3.64 17.28%
EPS Diluted 8.89 11.66 14.33 7.39 5.86 5.17 3.32 17.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.